The trend globally for mothers to breastfeed has highlighted the need for information on drug transfer into breast milk and the extent to which the suckling neonate may be exposed and affected. This reviewdiscusses robust study methodologies that will yield high-quality information on all aspects of this process. Methods for assessing drug transfer into breast milk are examined. The place of the milk/plasma ratio, the amount of drug in breast milk, and the volume of milk produced are discussed in the context of their utility in estimating both absolute and relative infant dose. The measurement of plasma drug concentrations and pharmacodynamic effects in the breastfed infant exposed to drugs are identified as important factors that can assist in deciding whether drug present in breast milk is a significant risk for the nursing infant.
Allen JC, Keller RP, Archer PC, et al. Studies in human lactation: milk composition and daily secretion rates of macronutrients in the first year of life. Am J Clin Nutr. 1991;54:69-80.
2.
Begg EJ, Malpas TJ, Hackett LP, et al. Distribution of R and S-methadone into human milk at steady state during ingestion of medium to high doses. Br J Clin Pharmacol. 2001;52:681-685.
3.
Kristensen JH, Ilett KF, Hackett LP, et al. Distribution and excretion of fluoxetine and norfluoxetine in human milk. Br J Clin Pharmacol. 1999;48:521-527.
4.
Kristensen JH, Ilett KF, Dusci LJ, et al. Distribution and excretion of sertraline and N-desmethylsertraline in human milk. Br J Clin Pharmacol. 1998;45:453-457.
5.
Rossi DT, Wright DS. Analytical considerations for trace determinations of drugs in breast milk. J Pharmaceut Biomed Analysis. 1997;15:495-504.
6.
Chan CF, Chiswell GM, Bencini R, et al. Quantification of naltrexone and 6, beta-naltrexol in plasma and milk using gas chromatographymass spectrometry: application to studies in the lactating sheep. J Chromatogr B: Biomed Sci Appl. 2001;761:85-92.
7.
Hill RC, McIvor RJ, Wojnar-Horton RE, et al. Risperidone distribution and excretion into human milk: case report and estimated infant exposure during breast-feeding [letter]. J Clin Psychopharmacol. 2000;20:285-286.
8.
Wojnar-Horton RE, Hackett LP, Yapp P, et al. Distribution and excretion of sumatriptan in human milk. Br J Clin Pharmacol. 1996;41:217-221.
9.
Wojnar-Horton RE, Kristensen JH, Yapp P, et al. Methadone distribution and excretion into breast milk of clients in a methadone maintenance programme. Br J Clin Pharmacol. 1997;44:543-547.
10.
Rampono J, Kristensen JH, Hackett LP, et al. Citalopram and demethylcitalopram in human milk: distribution, excretion and effects in breast fed infants. Br J Clin Pharmacol. 2000;50:263-268.
11.
Yapp P, Ilett KF, Kristensen JH, et al. Drowsiness and poor-feeding in a breast-fed infant: association with nefazodone and its metabolites. Ann Pharmacother. 2000;34:1269-1272.
12.
Wilson JT, Brown RD, Hinson JL, et al. Pharmacokinetic pitfalls in the estimation of breast milk plasma ratio for drugs. Ann Rev Pharmacol Toxicol. 1985;25:667-689.
13.
Briggs GG, Samson JH, Ambrose PJ, et al. Excretion of bupropion in breast milk. Ann Pharmacother. 1993;27:431-433.
14.
Begg EJ, Duffull SB, SaundersDA, et al. Paroxetine in human milk. Br J Clin Pharmacol. 1999;48:142-147.
15.
Hall B. Changing composition of human milk and early development of appetite control. Lancet. 1975;1:779-781.
16.
Kemp J, Ilett KF, Booth J, et al. Excretion of doxepin and Ndesmethyldoxepin in human milk. Br J Clin Pharmacol. 1985;20:497-499.
17.
Ilett KF, Lebedevs TH, Wojnar-Horton RE, et al. The excretion of dothiepin and its primary metabolites in breast milk. Br J Clin Pharmacol. 1992;33:635-639.
18.
Stowe ZN, Cohen LS, Hostetter A, et al. Paroxetine in human breast milk and nursing infants. Am J Psychiatry. 2000;157:185-189.
19.
Atkinson HC, Begg EJ. Relationship between human milk lipidultrafiltrate and octanol-water partition coefficients. J Pharm Sci. 1988;77:796-798.
20.
Green D, Moye L, Schreiner RL, et al. The relative efficacy of four different methods of human milk expression. Early Hum Dev. 1982;6:153-159.
21.
Daly SE, Di Rosso A, Owens RA, et al. Degree of breast emptying explains changes in the fat content, but not fatty acid composition, of human milk. Exp Physiol. 1993;78:741-755.
22.
Neville MC, Walsh CT. Effects of drugs on milk secretion and composition. In: Bennett PN, ed. Drugs and Human Lactation. Amsterdam: Elsevier; 1996:15-46.
23.
Chambers CD, Anderson PO, Thomas RG, et al. Weight gain in infants breastfed by mothers who take fluoxetine. Pediatrics. 1999;104:e61-e61.
24.
da Silva OP, Knoppert DC, Angelini MM, et al. Effect of domperidone on milk production in mothers of premature newborns: a randomized, double-blind, placebo-controlled trial. Can Med Assoc J. 2001;164: 17-21.
25.
Arthur PG, Hartmann PE, Smith M. Measurement of the milk intake of breast-fed infants. J Pediatr Gastroenterol Nutr. 1987;6:758-763.
26.
Daly SE, Kent JC, Huynh DQ, et al. The determination of short-term breast volume changes and the rate of synthesis of human milk using computerized breast measurement. Exp Physiol. 1992;77:79-87.
27.
Cregan MD, Hartmann PE. Computerized breast measurement from conception to weaning: clinical implications [review]. J Hum Lact. 1999;15:89-96.
28.
Begg EJ, Atkinson HC. Modelling of the passage of drugs into milk [review]. Pharmacol Ther. 1993;59:301-310.
29.
Silprasert A, Dejsarai W, Keawvichit R, et al. Effect of storage on the creamatocrit and total energy content of human milk. Hum Nutr Clin Nutr. 1987;41:31-36.
30.
Bennett PN. Use of the monographs on drugs. In: Bennett PN, ed. Drugs and Human Lactation. Amsterdam: Elsevier; 1996:67-74.
31.
Begg EJ. Clinical Pharmacology Essentials: The Principles Behind the Prescribing Process. Auckland, New Zealand: Adis International; 2002.
32.
Rossiter EJ. The use of developmental screening and assessment instruments by paediatricians in Australia. J Paediatr Child Health. 1993;29:357-359.
33.
Frankenburg WK, Dodds JB. The Denver Development Screening Test. J Pediatr. 1967;71:181-191.
34.
Epperson N, Czarkowski KA, Ward-O’Brien D, et al. Maternal sertraline treatment and serotonin transport in breast-feeding motherinfant pairs [see comments]. Am J Psychiatry. 2001;158:1631-1637.
35.
Ostrea EM, Chavez CJ, Strauss ME. A study of factors that influence the severity of neonatal narcotic withdrawal. J Pediatr. 1976;88:642-645.
36.
Malpas TJ, Darlow BA, Lennox R, et al. Maternal methadone dosage and neonatal withdrawal. Aust N Z J Obstet Gynaecol. 1995;35:175-177.
37.
Spencer MJ, Escondido CA. Fluoxetine hydrochloride (Prozac) toxicity in a neonate. Pediatrics. 1993;92:721-722.
38.
Nordeng H, Bergsholm YK, Bohler E, et al. [The transfer of selective serotonin reuptake inhibitors to human milk]. Tidsskrift for Den Norske Laegeforening. 2001;121:199-203.
39.
Chambers CD, Johnson KA, Dick LM, et al. Birth outcomes in pregnant women taking fluoxetine [see comments]. N Engl J Med. 1996;335:1010-1015.
40.
Committee on Drugs, American Academy of Pediatrics. The transfer of drugs and other chemicals into human milk. Pediatrics. 2001;108: 776-789.
41.
Hale TW, Ilett KF. Drug Therapy and Breastfeeding: From Theory to Clinical Practice. London: Parthenon Press; 2002.
